The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online June 25, 2007
doi:10.1084/jem.20062120
The Journal of Experimental Medicine, Vol. 204, No. 7, 1533-1541
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Codarri et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Codarri, L.
Right arrow Articles by Pantaleo, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Codarri, L.
Right arrow Articles by Pantaleo, G.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BRIEF DEFINITIVE REPORT

Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7R{alpha}high cell population in solid organ transplant recipients

Laura Codarri1, Laure Vallotton1, Donatella Ciuffreda1, Jean-Pierre Venetz2, Miguel Garcia1, Karine Hadaya4, Leo Buhler4, Samuel Rotman3, Manuel Pascual2, and Giuseppe Pantaleo1

1 Laboratory of AIDS Immunopathogenesis, Division of Immunology and Allergy, Department of Medicine, 2 Transplantation Center, and 3 Institute of Pathology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, 1011 Lausanne, Switzerland
4 Service of Nephrology and Transplantation, Hôpitaux Universitaires de Genève, University of Geneva, 1211 Geneva 14, Switzerland

CORRESPONDENCE Giuseppe Pantaleo: giuseppe.pantaleo{at}chuv.ch OR Manuel Pascual: manuel.pascual{at}chuv.ch

It has been recently shown (Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S.I. Alexander, R. Nanan, et al. 2006. J. Exp. Med. 203:1693–1700.) that the expression of interleukin (IL) 7 receptor (R) {alpha} discriminates between two distinct CD4 T cell populations, both characterized by the expression of CD25, i.e. CD4 regulatory T (T reg) cells and activated CD4 T cells. T reg cells express low levels of IL-7R{alpha}, whereas activated CD4 T cells are characterized by the expression of IL-7R{alpha}high. We have investigated the distribution of these two CD4 T cell populations in 36 subjects after liver and kidney transplantation and in 45 healthy subjects. According to a previous study (Demirkiran, A., A. Kok, J. Kwekkeboom, H.J. Metselaar, H.W. Tilanus, and L.J. van der Laan. 2005. Transplant. Proc. 37:1194–1196.), we observed that the T reg CD25+CD45RO+IL-7R{alpha}low cell population was reduced in transplant recipients (P < 0.00001). Interestingly, the CD4+CD25+CD45RO+IL-7R{alpha}high cell population was significantly increased in stable transplant recipients compared with healthy subjects (P < 0.00001), and the expansion of this cell population was even greater in patients with documented humoral chronic rejection compared with stable transplant recipients (P < 0.0001). The expanded CD4+CD25+CD45RO+IL-7R{alpha}high cell population contained allospecific CD4 T cells and secreted effector cytokines such as tumor necrosis factor {alpha} and interferon {gamma}, thus potentially contributing to the mechanisms of chronic rejection. More importantly, CD4+IL-7R{alpha}+and CD25+IL-7R{alpha}+ cells were part of the T cell population infiltrating the allograft of patients with a documented diagnosis of chronic humoral rejection. These results indicate that the CD4+CD25+IL-7R{alpha}+ cell population may represent a valuable, sensitive, and specific marker to monitor allospecific CD4 T cell responses both in blood and in tissues after organ transplantation.


L. Codarri and L. Vallotton contributed equally this study.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Keeping score of antigraft T cells
Hema Bashyam
J. Exp. Med. 2007 204: 1505. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS